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Abstract 
Oxidative damage caused by free radicals has been implicated in the 
development of age-related macular degeneration [ARMD). Recent studies suggest 
that antioxidant vitamins and minerals can be useful in the management or prevention 
of this condition. To assess the normal dietary intake of the antioxidant s, 28 healthy 
subjects 55 years of age and over completed a diet survey. Of the 28 subjects, 26 
were found to have deficient intakes; zinc and selenium were the most commonly 
deficient nutrients. 
Two over-the-counter (OTCJ nutritional supplements that make claims about the 
antioxidant nutrients they contain (ICAPS-Pius® and Ocuvite®J were evaluated with 
respect to their ability to raise blood levels of two important antioxidant nutrients: zinc 
and beta-carotene. In a masked, cross-over study, ICAPS-Pius® and Ocuvite® 
significantly raiser mean serum zinc levels 24.7% and 1 8%; respectively; I CAPS-Plus® 
significantly raised mean beta-carotene levels by 21 .4 %, but Ocuvite® did not change 
the mean level significantly. Based on the probable relationship between antioxidant 
levels and diseases such as ARMD, these results suggest that OTC supplements 
might be useful for selected patients. 
KEYWORDS 
Free radical, antioxidant, vitamin, mineral, age-related macular degeneration, zinc, 
beta-carotene, diet. 
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INTRODUCTION 
Optometrists are often involved in the diagnosis and management of patients 
with age-related macular degeneration. Approximately 1 0% of ARMD patients have 
the wet form of the disease that is characterized by acute central visual acuity loss 
af!d hemorrhages near the macula. The remaining 90% have the dry form of ARMD 
characterized by reduced central acuity and the presence of drusen. Patient s with 
\!ifet.ARMD are often treated by laser photocoagulation, but patients with the dry forr;·1 
ar-e currently offered little more than a take-home Amsler grid to monitor their 
condition. Fortunately, recent discoveries seem to offer hope for the prevention 
and/ or management of ARMO. For example, it is now believed that light-generated 
free radicals play an important role in the etiology of this condition. 1-3 If this is correct, 
it might be possible to supplement the body's natural defenses against free radicals 
thus protecting the eyes from ARMO. 
Free Radicals 
A free radical is a highly reactive atom or molecule that has one or more 
unpaired electrons. Since a molecule is most stable when every electron is paired with 
one of opposite spin, a free radical will attack another molecule from which it can take 
an electron. During this process, the attacked molecule is often converted to a free 
radical which can attack another molecule thus perpetuating a cascade of free radical 
reactions. In biological systems, the damage to tissue resulting from free radical 
attack has been implicated in diseases such as cancer, and is believed by some to 
contribute to the aging process.4-7 
Normally, the antioxidant defense mechanisms within the body provide a 
reasonable degree of protection against free radical attack. These defenses include 
antioxidant compounds, such as vitamins C, E, and beta-carotene (a pro-vitamin form of 
vitamin A) that react with free radicals to quench their reactivity.8 Antioxidant 
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defenses also include various enzymes, such as superoxide dismutase, glutathione 
peroxidase, and catalase.5 These enzymes require the essential trace minerals 
selenium, zinc, manganese, and copper as cofactors for their proper function. 
Deficient dietary intakes of the antioxidant vitamins and minerals can decrease the 
effectiveness of the body's natural antioxidant defenses, and can allow cells t o become 
overwhelmed by free radicals.6 ·8 
Free Radical Damage in the Retina 
Free radicals can be formed in t he retina by energy liberat ed from quanta that 
are absorbed, especially quanta with energies in the ultraviolet (UV) and blue part of 
the spectrum.9 This energy can produce free radicals, or it can convert molecular 
oxygen to a highly reactive, excited state called singlet oxygen.10 Singlet oxygen can 
damage tissue in a manner similar to free radicals, and it can also produce free 
radicals. 
Within the photoreceptor outer segments are plasma membranes containing 
numerous lipid molecules. These lipid molecules have many double bonds that can be 
easily attacked by free radicals to release electrons. As the lipid molecules give up 
electrons, t hey are altered and/ or converted to free radicals themselves. This 
chain-r·eaction can continue until the free radicals are quenched by interacting with 
antioxidants that provide electrons to the free radicals without becoming free radicals 
themselves. 
If the altered lipids and free radicals accumulate within the receptor outer 
segments, the possibility of receptor injury increases." To reduce this possibility, older 
portions of the outer segments are phagocytized by the retinal pigment epithelium 
(APE). However, some of the altered lipid molecules in the phagocytized outer 
segment material are not recognized by the RPE digestive enzymes due to their 
changed structure, so they accumulate as "unrecyclable" lipofuscin and other 
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compounds inside the RPE cells. 1 This material can ultimately be excreted onto 
8f'uch•s membrane in the form of drusen that physically separate the APE from its 
blood supply in the choroid. This reduces the ability of the APE to provide metabolic 
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support for the photoreceptors and can result in their death. Death of the receptors 
leads t o the reduction of central vision characteristic of ARMD. 
Protection Against Free Radical Damage in the Retina 
Many studies have demonstrated the beneficial and protective effects of 
antioxidant vitamins and minerals against light-induced retinal damage. Animals fed 
diets deficient in vitamins C and E showed increased light-induced retinal 
degeneration,11 ·12 and diets enhanced with vitamins c: E, and beta-carotene have been 
shown to protect the retina from light damage. 13-16 
The protective effects of the antioxidants can also be demonstrated in humans. 
Data collected in the National Health and Nutrition Examination Survey show that 
people who consume fruits and vegetables inherently rich in beta-carotene have a 
reduced incidence of ARMD. 17 
Certain minerals have been found to provide protection against free radical 
damage in the retina. Data suggest that the high concentration of selenium found in 
the human RPE is due to its antioxidant role as a cofactor in enzymes that reduce free 
radicals damage.18 In addition, selenium plasma levels [as measured via levels of 
glutathione peroxidase which is a selenium dependent antioxidant enzyme) were found 
to be inversely correlated to the degree of ARMD in patients with this disease.19 
Zinc could be especially important in the antioxidant protection of the eye 
because of its high concentration in the choroid and retina. 20·21 Catalase (an 
antioxidant enzyme dependent upon zinc and copper] is very active in the APE, and this 
suggests that zinc plays an important role in the retinal antioxidant defenses.22 
Additionally, a decrease in the catalase activity has been noted from the sixth to ninth 
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decades of human life when ARMO frequency increases, and the decrease is more 
pronounced in eyes with ARMD.22 This suggests that a reduction in catalase activity 
might be associated with ARMD pathogenesis. 
Enhancement of Antioxidant Levels by Supplementation 
Pilot studies have investigated the value of antioxidant vitamin and mineral 
supplements for ARMO patients and have made strong cases for their use. In a 
landmark study, patients suffering from ARMD were given oral zinc sulfate 
supplements over a two year period and were found to suffer significantly less vision 
loss than controls. 23 Objective comparisons of macular photographs before and after 
intervention showed that the zinc treated group either remained stable or had less 
accumulation of visible drusen than did controls. Other studies have shown that 
ARMD patients taking antioxidant supplements exhibited improvement or stability to 
their visual acuity and contrast sensitivity measures.24·8 
Because of these suggestive findings, several companies are now producing 
OTC supplements containing antioxidant vitamins and minerals directed at the eyecare 
market. Two representative products are ICAP&Pius® band Ocuvite®c; Figure 1 
illustrates these products. 
Insert Figure 1 About Here 
Although the products contain similar antioxidant nutrients, they differ in 
concentrations and chemical composition, particularly for zinc. ICAP&Pius® contains 
the acetate form of zinc, and Ocuvite® contains zinc oxide. La Haye Laboratories, 
manufacturer of ICAP&Pius®, states in promotional literature that " .... there is a 
considerable difference in the bioavailability of zinc oxide and zinc acetate, with zinc 
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acetate being much more absorbed of the two .... "b They also suggest the use of this 
fact as a basis for recommending their product to patients. Lederle, the manufacture:r 
of Ocuvite®, states in its advertisements that " .... zinc oxide is the most concentrated 
form of zinc .... '' and " .... Ocuvite® tablets contain more zinc than any·other leading 
multivitamin/ multimineral supplement .... "c (The package labels show that Ocuvite® 
contains 40 mg of zinc in t he form of zinc oxide, whereas ICAPS-Pius(B) contains 30 c ·-
of zinc in the form of zinc acetate). The effects of these two forms of zinc have been 
investigated during a period of several hours following ingestion and one study has 
shown zinc acetate does have greater bioavailability.25 However, zinc has also been 
reported to have an extremely variable absorption rate that can be dependent on the 
diet and possible interactions with other micronutrients present during digestion.26 
Another difference between the two products is the amount of beta-carotene 
contained in eact ~ tablet; ICAP&Pius® provides 6000 I.U. and Ocuvite® provides 5000 
I.U. Because beta-carotene also has an extremely variable absorption rate, it is 
uncertain how much of this nutrient is needed to increase blood levels. This is 
important because beta-carotene levels in the retina have been shown in animal 
studies to be dose-dependent and correlated to levels in the blood.16 Therefore, if 
supplements could produce higher blood levels of beta-carotene, they should also 
produce higher retinal levels thereby enhancing the retina's antioxidant defenses. 
Project Goals 
This project had three goals. The first was to determine if the dietary intakes of 
antioxidant vitamins and minerals were adequate in a typical population of normal, 
healthy adults over 55 years of age. If the intakes were deficient, the second goal was 
to determine if the two representative supplements (ICAPS-Pius® and Ocuvite®) could 
raise antioxidant serum levels. The third goal was to compare product attributes and 
patient acceptance of the two supplements. 
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SUBJECTS and METHODS 
Thirty subjects were selected from volunteers who responded to newspaper 
articles and direct solicitations at senior citizen centers. Subjects were required to be 
age 55 or older and have good general health. All subjects participated in a detailed 
screening interview and were given a dilated fundus examination to detect ARMO or 
other ocular pathology. Excluded were cigarette smokers, and those with cancer, 
gastrointestinal disease, diabetes mellitus, or other serious systemic health problems. 
People with ARMD, cataracts causing worse than 20/30 vision, and other ocular 
diseases such as glaucoma were also excluded .. Those taking any vitamin and mineral 
supplements were required to discontinue their use at least seven days prior to the 
start of the study. Following an explanation of the study, all subjects signed an 
informed consent document. Each subject who completed the study was paid forty 
dollars. 
Diet Assessment 
Subjects were required to maintain a written food intake diary for a four week 
period. A logbook was provided with directions stressing the need for detailed food 
descriptions and accurate determinations of quantities. Compliance with these 
instructions was checked by telephone at the end of the first week and by actual 
inspection of the log after two weeks. Data from the logbooks were analyzed using the 
Nutritionist IV d computer program to determine the average daily intake levels of 
several antioxidant nutrients. The nutrients examined were vitamins C and E, 
beta-carotene, and the minerals zinc, copper, manganese and selenium. 
Supplementation Trials 
To evaluate the ability of two supplements to raise antioxidant levels, 
!CAPS-Plus® or Ocuvite® were supplied to each subject for two week trials. The order 
of supplement administration was counterbalanced so that half of the subjects took 
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Ocuvite® for the first two weeks and half took ICAPS-Pius® first. This was followed by 
a two week washout period during which no supplements were taken. Subjects were 
then provided with a two week supply of the other product. Supplement intake 
followed the dosage and protocol guidelines for ICAPS-Pius® and Ocuvite®: one tablet 
was taken two times daily with meals for both products. 
Blood Analysis 
Blood samples were drawn by a certified phlebotomist at the beginning of 
supplementation with the first product and at the end of the initial two week 
supplement period. Blood was again drawn following the two week washout period, 
and after two weeks of supplementation with the second product. All blood samples 
were drawn at the same hour of the day, and within three hours after ingestion of the 
supplement tablet taken with breakfast. 
A certified commercial medical laboratory analyzed each blood specimen for zinc 
and beta-carotene serum levels.8 Zinc serum levels were measured by flame atomic 
absorption spectrophotometry using a Perkin-Elmer Model 1 07 spectrophotometer, 
and beta-carotene serum levels were measured by spectrophotometry using a 
Beckman 24 UV-visible spectrophotometer following extraction with petroleum ether. 
Standard quality controls and calibration procedures were used by the laboratory. 
Zinc and beta-carotene were selected for analysis because of their significant 
antioxidant activities and because of the competing claims made by the supplement 
manufacturers. Other antioxidant vitamins and minerals could have also been 
analyzed, but expenses prohibited these additional analyses. 
Subjects' Evaluation of the Supplements 
Subject acceptance of the two supplements was determined during oral 
interviews. Areas evaluated included product odor, taste, ease of swallowing, 
gastrointestinal or other difficulties, compliance problems, overall preference, and cost 
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acceptance. The interviews were completed at the conclusion of each two week 
supplemention period. 
RESULTS 
Twenty-eight of the 30 subjects completed the study; two discontinued for 
personal reasons unrelated to the supplement use. The 28 subjects included 9 males 
and 17 females with ages ranging from 55 to 84 (mean age = 67; SO= 8). 
Diet Assessment 
Table 1 lists the compositions of subjects• diets as compared to the average 
adult diet and to the ideal diet as recommended by nutritionists.27 The carbohydrate, 
protein, and fat composition of the subjects• diets were quite similar to those reported 
in the average diet for normal adults.28 This suggests that the subjects in this study 
were reasonably representative of the general population. 
Insert Table 1 About Here 
Computer analysis of each subjeces nutrient intakes showed that 26 of the 28 
subjects were deficient in at least one of the antioxidant nutrients; moreover, 21 had 
deficiencies in two or more nutrients. Table 2 lists each subject•s daily average intake 
for each nutrient. The shaded portions of the table represent intake levels below the 
Recommended Dietary Allowances (ADA). (See Appendix A) Beta-carotene has no 
ADA, so there are no shaded portions. 
Insert Table 2 About Here 
Deficiency determinants were based on comparison to standards listed in the 
1989 (1Oth Edition) National Research Council Recommended Dietary Allowances for 
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3dults 51 years of age and above.29 The minerals zinc and selenium were the most 
commonly deficient antioxidant nutrients with 75% of the subjects having deficient 
intakes. Of the two vitamins analyzed, vitamin C intakes were adequate for all subjects, 
but vitamin E intakes were deficient for 54% of them. 
Supplementation Results 
Results of supplementation with ICAPS-Pius® and Ocuvite® on serum zinc levels 
are shown on Table 3. To compare the affects of each pr oduct on serum levels, 
repeated-measures analyses of variance (ANOVA) wit h post-hoc Scheffe tests were 
used. Based on these tests, both ICAP&Pius® and Ocuvite® raised serum levels 
significantly (p < 0.05). There was no significant difference between the increases 
produced by the two products (p > 0.05); neither one was shown to be significantly 
more effective than the other . 
Insert Table 3 About Here 
To evaluate the effectiveness of the washout, serum levels before any 
supplementation were compared to levels after the washout phase. Table 4 shows 
these values. Although the serum levels at the end of washout period appear to be 
higher for both ICAPS-PiusCt:D and Ocuvite®, neither increase is significant (t-test, p > 
~(]5) . Hnwr~vr~r. when the data are averaged for both products, the zinc ser~um level 
at the end of washout is significantly higher than the pre-supplementation level (t-test, 
p < 0.05). This suggests that there is a tendency for the body to retain zinc at least 
during the two week washout which is consistent with studies that propose zinc 
accumulates into soft body tissue and then is slowly released into the blood. 30·3 1 
II 
Insert Table 4 About Here 
@ Results of supplementation on beta-carotene levels are shown on Table 5. A 
repeated-measures ANOVA and Scheffe testing indicates that the !CAPS-Plus® raised 
beta carotene levels significantly, but Ocuvite® did not. Although the Ocuvite® 
post-supplementation beta-carotene serum levels are suggestively higher than the 
baseline values, the magnitude of the change is not statistically significant. 
Insert Table 5 About Here 
With respect to beta-carotene clearance during the washout period, analyses of 
the data in Table 6 indicate that the pre-supplementation and post-washout levels are 
not significantly different for either product nor for the combined data (t~tests; p > 
0.05). Unlike zinc, beta carotene was not retained in the body during the two week 
washout period. 
Insert Table 6 About Here 
Subjects' Evaluation of the Supplements 
Based on the interview data, Ocuvite® was preferred by half of the subjects; the 
other half either had no preference (4 subjects) or a preference for !CAPS-Plus® (1 0 
subjects). Comments from the subjects are shown in Table 7, and additional interview 
data are shown in Figure 2. The majority of subjects reported no odor or taste 
problems with either of the products. Many found swallowing to be somewhat easier 
with Ocuvite®, probably because of its smaller size [ 14 x 8.5 x 6 mm versus 20 x 8 x 
12 
6 mm for ICAPS-Pius®). Ease of swallowing was the most common reason for 
preferring Ocuvite®. 
Insert Table 7 and Figure 2 About Here 
A few subjects experienced mild, transitory stomach upsets with both products, 
but no subjects had to discontinue their use. Subjects were instructed to take the 
tablets with meals, and most stomach upsets occurred when they were taken on an 
empty stomach. The stomach discomfort was most likely due to the zinc content of 
the tablets; zinc doses above 25 mg have been shown to produce epigastric distress 
and nausea.32 The solution to this problem was strict adherence to instructions 
regarding when to take the tablets; all of the subjects reported a cessation of 
discomfort when tablets were consumed with meals. 
A common observation reported during supplementation with ICAP&Pius® was 
a strong yellowing of the urine; this phenomena occurred only with ICAPS-Pius® 
because it includes the water soluble B-12 vitamin, riboflavin. Riboflavin plays a role in 
the metabolism of erythrocyte glutathione peroxidase, but it has no direct antioxidant 
activity. Its concentration in ICAP&Pius® exceeds the RDA by over 1 000 times, but 
no toxic level is known for this nutrient.33 Ocuvite® does not contain riboflavin. 
The cost of these products is approximately $6.00 to $9.00 for a one month 
supply. Few subjects felt that this amount was excessive, and the majority stated they 
would be inclined to pay for the supplements if they were prescribed by an 
optometrist. 
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DISCUSSION 
The goals of this project were to evaluate dietary antioxidant intake levels of 
normal subjects, to determine if supplements could raise antioxidant serum levels, and 
to compare the product attributes and patient acceptance of two representative 
supplements. 
Diet Analysis 
Diet analyses of the normal individuals in this study make a strong case for 
dietary supplementation: the majority (26 of 28) were deficient in at least one 
antioxidant nutrient. This is consistent with other reports in which diet deficiencies for 
zinc and other minerals have been noted.34-36 Some nutritionists believe that vitamin 
and mineral deficiencies can be avoided by consuming a well-balanced diet,37·38 but 
when 37 adults who were interested in eating a healthy diet attempted to follow a set 
of dietary recommendations, they were still zinc deficient.39 Changing life-long dietary 
habits can be a difficult undertaking so the use of dietary supplementation might be a 
more reasonable way to prevent deficiencies. 
Effects of Supplements on Serum Levels 
This study demonstrated that the zinc formulations found in ICAPS-Pius® and 
Ocuvite® were both capable of increasing blood serum levels and that the increases 
produced by the two products were not statistically different. This is interesting 
because the products contain different forms of zinc and the manufacturers have 
made conflicting claims about the superiority of their particular zinc formulation. 
These claims of superiority are not supported by the results of this study. 
Of the two products, only ICAP&Pius® produced a significant increase in serum 
levels of beta-carotene; Ocuvite® failed to change the beta-carotene serum levels 
significantly from the baseline. This difference is most likely due to the greater amount 
of beta-carotene found in ICAP&Pius®. (Table 5) Interactions between the various 
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components in supplements and/ or the amount of fat in the diet have also been 
suggested as possible factors that can change the bioavailability of beta-carotene.40 
Since the level of beta-carotene in the retina has been correlated with the blood level, 
the serum increases produced by ICAP&Pius® could indicate an enhancement of thE 
subjects• ocular antioxidant defenses. The ability of ICAP&Pius® to significantly 
increase the beta-carotene levels seems to make this product a good choice for 
patients. 
Risks Associated with the Use of Supplements 
Table 5 shows the nutrient quantities supplied by two tablets of each product 
added to the average daily nutrient amounts consumed by the subjects in this study. 
In all cases the totals are below known toxic levels; this indicates that use of 
supplements should not present a health risk for normal patients on typical diets. 
Insert Table 8 About Here 
Selection of a Supplement 
The representative products used in this study are among several on the OTC 
market. Certain considerations should be kept in mind when selecting or 
recommending one of these products. For example, zinc and copper compete for 
similar binding sites during absorption, and daily zinc ingestion of 15 to 25 mg c~n 
produce a copper deficiency anemia.4143 Thus any product that includes zinc but not 
copper should be used with care. (Patients with Wilson's disease, a copper 
metabolism disorder having a Kayser-Fleisher ring as a common ocular presentation 
should probably avoid any supplements containing copper.) 
Many of the antioxidant supplements list vitamin A as a component, but 
beta-carotene (the pro-form of vitamin A) is an antioxidant whereas vitamin A is not. 
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For this reason, if a label lists vitamin A as an ingredient, care must be taken to insure 
that the product actually contains beta-carotene. Beta-carotene is safe even in large 
dosages because its conversion to vitamin A is limited,44 but vitamin A can have toxic 
effects if too much is taken.45 
Other factors to consider when selecting a supplement include the quantities of 
ingredients indicated on the bottle labels, and any ingredients besides the antioxidants 
that the supplement contains (e.g., ICAP&Pius® contains riboflavin). 
Taking dietary supplements similar to the ones evaluated in this study would 
insure that patients receive at least the ROA for the antioxidant nutrients, but the 
actual amounts needed to provide the greatest antioxidant defense enhancement still 
remain to be determined. Obviously, these optimal amounts will lie somewhere 
between the minimum level needed to prevent nutrient deficiency and the level at 
which toxicity occurs. For this reason, most supplements contain many times the 
RDAs for those nutrients that have very high or unknown toxic levels. A good example 
of the need for including high levels of some nutrients can be seen in the effects of 
beta-carotene supplementation on serum levels in this study. Ocuvite® contains 1 00% 
of the vitamin A equivalent RDA of beta-carotene, but it failed to raise serum levels 
significantly whereas ICAP&Pius®, containing 120% of the RDA. did. 
Additionally, it is still unknown which antioxidants are the most crucial in 
preventing disease. Very high levels of some antioxidants might not necessarily 
compensate for deficiencies in other antioxidants. It is also possible that certain 
antioxidants could have synergistic effects, so that one missing nutrient might impact 
the entire antioxidant defense system. 
A large scale efficacy study involving 2400 patients at eight study centers is 
currently evaluating the individual antioxidant nutrients for their ability to halt the 
progression of ARM0. 8 This study should provide more definitive information as to the 
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quantities of various antioxidant nutrients that are needed to optimize the body's 
protective mechanisms. For now, however, it seems appropriate to select a 
supplement that contains as broad a range of antioxidants as possible. 
CONCLUSIONS 
Prior to recommending an antioxidant supplement for the prevention or 
management of ARMD, several important questions must be considered. First, is it 
r easonable to believe that ARMD is associated with free radical damage in the eye? 
Althouqh the available evidence is not yet overwhelming, it does suggest that the 
answer to this question is yes. Then, if free radical damage is associated with ARMO, 
can supplementation with antioxidant nutrients help the body to reduce or prevent the 
damage? The answer to this question is more speculative than the answer to the first 
question, but, in theory, the answer also seems to be yes. Typical patients, especially 
those over 55 years of age, do not appear to get enough of the antioxidants in their 
normal diets, so supplementation seems justified. 
Finally, if it is appr·opriate to recommend antioxidant supplements, which of the 
various OTC products is most appropriate. It seems clear that any recommended 
supplement should contain all of the known antioxidants at levels that are as high as 
possible without risking toxic or unpleasant side-effects. Beyond this, any additional 
ingredients (such as the riboflavin in ICAPS-Pius®) should be evaluated individually for 
value or risk. With respect to the two products in this study, the ability of ICAP&Pius® 
to' raise beta-carotene levels would seem to give it an advantage over Ocuvite®. 
More convincing proof for the efficacy of dietary supplementation in the 
prevention and management of ARMD is surely needed, however to wait for this 
evidence before prescribing supplements could put patients at risk. Supplements 
might therefore be considered for patients with deficient diets, for those with 
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significant exposure to free radical inducing agents such as excessive UV or blue light, 
and/ or for patients with a personal or family history of ARMD. 
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Appendix A: The U.S. ADA versus the ADA 
The RDAs used in this study are based on standards established in 1989 by t he 
Food and Nutrition Board of the National Research Council and the National Academy 
of Sciences. However, some of the information currently found on vitamin and mineral 
bottle labels is not in agreement these standards. Instead, most label information is 
based on the U.S. RDA that was established by the U.S. Food and Drug Administration 
(FDA) on the basis of recommendations made in 1968. 
Differences between the two standards (U.S. ROA versus the ADA) include 
recommended nutrient amounts and in the way in which some nutrients are 
measured. For example, with U.S. ROA labeling, selenium is listed as having no 
recommended allowance. However, the ADA recommends 70 meg for men and 55 
meg for women. 
In the new standards, units of measure such as lntemational Units (IU) have also 
been replaced with units that reflect estimated biological activity. For example, the 
RDA uses retinol equivalents (RE) for vitamin A, and d-a-tocopherol equivalents (TE) for 
vitamin E. 
Another difference involves the way vitamin A and beta-carotene are specified. 
The older 1968 labeling standard lists beta-carotene as being essentially the same as 
vitamin A, but beta-carotene has antioxidant properties whereas vitamin A does not. 
Beta-carotene is currently measured in retinol equivalents only because it can serve as 
a source of vitamin A after conversion within the body. 
A fourth difference between the U.S. RDA and the RDA is that the RDA specifies 
different nutritional recommendations based on age groups such as infants, children, 
adults, etc. 
A good source book for additional information regarding the subject of nutrition 
and recommended nutrients is the 1Oth edition of Recommended Dietary Allowances 
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published by the National Academy Press. 28 It is possible that some of the confusion 
between the ADA and the U.S. ADA will soon be eliminated because in 1991 the FDA 
proposed to bring the U.S. ADA into closer conformation with the RDA. Acceptance of 
this proposal is currently being considered. 
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Table 1: Diet Analysis 
Study Diet Average Diet* Ideal Diet"'* 
Carbohydrate 49.8% 45.3-52% 55-60% 
Protein 17.0% 14 -18% 12 -15% 
Fat 33 .2% 36.4% 30% 
* National Academy of Sciences. Recommended Dietary Allowances, lOth ed. Washington, DC: 
National Academy Press, 1989 
**Shils ME, Young VR, eds. Modem Nutrition in Health and Disease, 7th ed. Philadelphia: Lea 
& Febiger, 1988 
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Table 2: Dietary Intakes of Antioxidant Nutrients 
(shaded portions represent intake amounts below the ADA) 
Nutrient Vitamin C Vitamin E 
10 mg* 
Zinc Selenium Copper 
1.5 to 3.0 
Manganese B-carotene 
2.0 to 5.0 none 
* 1 mg vitamin E as d-a-tocopherol = 1.49 (IU) International Units of vitamin E = 1 TE (d-a-tocopherol 
equivalents) 
*" Estimated Safe and Adequate Daily Dietary Intakes from National Academy of Sciences. 
Recommended Dietary Allowances, 1oth ed. Washington, DC: National Academy Press, 1989 
*** b-carotene is a potent antioxidant with no RDA; it also serves as a non-toxic source of vitamin A 
which has an adult RDA of 1000 RE (male) and 800 RE (female). 
Retinol equivalents (RE) = 1 J.l9 retinol or 6 J.l9 b-carotene 
1000 RE = 10,000 IU of vitamin A 
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Table 3: Changes in Zinc Serum Levels 
Antioxidant Mean Serum Level Mean Serum Level Percent 
Supplement Before Supplementation After Supplementation Change 
mcg/dl (std dev) mcg/dl (std dev) (* SlgnJftcant) 
I CAPS-Plus® 91.4 (17.8) 113.9 (19.3) D24.7% * 
(28 subjects) 
Ocuvite® 93.5 (16.1) 111 (21.7) D18.7%* 
(28 subjects) 
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Table 4: Pre-supplement versus Post-washout Zinc Serum Levels 
Antioxidant Mean Senun Level Mean Serum Level After 
Supplement Before Supplementation Washout Period 
mc2fdl (std dev) mcg/dl (std dev) 
ICAPS-Plus® 87.5 (13.1) 99.5 (11.0) 
( 14 subjects) 
Ocuvite® 87.4 (18.4) 95.2 (21.2) 
(14 subjects) 
Mean Values 87.5 (15 .7) 97.4 (16.3) 
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Table 5: Changes in Beta-carotene Serum Levels 
Antioxidant Mean Serum Level Mean Serum Level Percent 
Supplement Before Supplementation After Supplementation Change 
meg/d) (std dev) mcg/dl (std dev) (* Significant) 
ICAPS-Plus® 177.2 ( 64.5) 215.1 (76.4) 1121.4% * 
(28 subjects) 
Ocuvite® 184.1 (70. 7) 200.5 (72.5) 118 .9% 
(28 subjects) 
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Table 6: Pre-supplement versus Post-washout Beta-carotene Serum Levels 
Antioxidant Mean Serum Level Mean Serum Level After 
Supplement Before Supplementation Washout Period 
meg/ell (std dev) mcafdl (std dev) 
I CAPS-Plus® 181.6 (50.4) 200.6 (69.9) 
(14 subjects) 
Ocuvite® 167.6 (70.1) 172.9 (77.8) 
(14 subjects) 
Mean Values 174.6 (60.3) 186.7 (73 9) 
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Table 7: Comments from subjects explaining a particular product preference. 
I CAPS-Plus® Ocuvite® 
better odor and easier to swallow smaller, easy to swallow 
product seemed more potent little or no taste 
felt more potent taste better 
easier to swallow, smoother coating, better color easier to tolerate 
easier to swallow better taste, better to swallow 
--
felt better taking the supplement no smell, no odor 
felt better after taking it no upset stomach 
felt I could see better using this product easy to swallow 
felt better smaller, easy to swallow 
pleasant smell felt vision was improved 
felt it did more good 
easier to take or swallow 
smaller, easier to swallow 
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Table 8: Antioxidant nutrients supplied by ICAP&Pius®, or Ocuvite®, plus dietary 
intakes as compared to Toxic Levels 
Nutrient Amount of Mean Daily Total Intake 
(RDA 51+ yrs )** Nutrient in Dietary Intake from Diet and Toxic Levels* 
Supplement (of subjects in Supplements 
(2 tablets) this study) 
Vitamin C I CAPS-Plus® 400mg 552 mg 
60mg 152 mg > 1000 mg 
Oeuvite® 120mg 272 mg 
Vitamin E !CAPS-Plus® 80mg 89.2 mg 
IOmg 9.2 mg > 536 mg 
Oeuvite® 40mg 49.2 mg 
Zinc !CAPS-Plus® 60 mg 71.9 mg 
d ISmg 11.9 mg > 150 mg 
~ 12 mg · Oeuvite® 80 mg 91.9 mg 
Selenium !CAPS-Plus® 60 meg 113 meg 
d 70mcg 53 meg > 500 meg 
? 55 meg Oeuvite® 80meg 133 meg 
Copper I CAPS-Plus® 3.0 mg 4.6mg 
1.5 to 3.0 mg J.6mg > 30.0 mg 
Ocuvite® 4.0 mg 5.6 mg 
Manganese I CAPS-Plus® lOmg 12.4 mg Safe at 9 mg 
2.0 to 5.0 mg 2.4mg Toxic intake level 
Ocuvite® none 2.4mg unknown 
fJ-carotene ICAPS-Plus® 1200 RE 2803 RE Safe at 30,000 RE 
No requirement 1603 RE Toxic intake level 
Ocuvite® 1000 RE 2603 RE unknown 
* National Academy of Sciences. Recommended Dietary Allowances, lOth ed. Washington, DC: National Academy 
Press, 1989 
** Shils ME, Young VR, eds. Modern Nutrition in Health and Disease, 7th ed Philadelphia: Lea & Febiger, 1988 
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Figure Captions 
Figure 1: Two nutritional supplements evaluated in this study: ICAP&Pius® and 
Ocuvite® 
Figure 2: Product Attributes and Preferences 
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